KDM2B-IN-3

KDM2B-IN-3 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 183c. KDM2B-IN-3 can be used for the research of cancer[1].

Product Specifications

CAS Number

[1966933-87-8]

UNSPSC

12352005

Target

Histone Demethylase

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/kdm2b-in-3.html

Solubility

10 mM in DMSO

Smiles

N#CCC1=C(OC)C=CC2=C1C=CC(C([C@@H]3[C@H](CCN(C4CCC4)C3)CC)=O)=C2

Molecular Formula

C25H30N2O2

Molecular Weight

390.52

References & Citations

[1]Albrecht BK, et, al. (piperidin-3-yl) (naphthalen-2-yl) methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer. WO2016112284A1.